A Randomized Study of 2 Dose Levels of Intravenous Clofarabine in the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome

類似資料

• Oral Clofarabine in the Treatment of Patients With Higher-Risk Myelodysplastic Syndrome
  著者:: Faderl, Stefan, 等
  出版事項: (2010)
• A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome
  著者:: Faderl, Stefan, 等
  出版事項: (2008)
• Clofarabine Combinations as Acute Myeloid Leukemia Salvage Therapy
  著者:: Faderl, Stefan, 等
  出版事項: (2008)
• Implications of discrepancy in morphologic diagnosis of myelodysplastic syndrome between referral and tertiary care centers
  著者:: Naqvi, Kiran, 等
  出版事項: (2011)
• Clofarabine Does Not Negatively Impact the Outcomes of Patients With Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation
  著者:: Mathisen, Michael S., 等
  出版事項: (2012)